Old Web
English
Sign In
Acemap
>
authorDetail
>
Kristy Drafahl
Kristy Drafahl
Oncology
Minimal residual disease
Molecular biology
ABL
breakpoint cluster region
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Development and Validation of a Highly Sensitive e1a2 (p190) BCR-ABL Test to Determine Complete Molecular Response (Minimal Residual Disease Negative) As a Primary Endpoint for Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
2018
Blood
Kristy Drafahl
David C. Smith
Cristen Graham
Christine Glynn
Cindy Spittle
Scott Verrow
Victor M. Rivera
Shouryadeep Srivastava
Kevin Hawkins
Chad Galderisi
Show All
Source
Cite
Save
Citations (0)
Development and Validation Of Highly Sensitive Mrdx BCR-ABL Test For Monitoring Deep Molecular Response In Patients With Chronic Myeloid Leukemia
2013
Blood
Julie Toplin
Kristy Drafahl
Jonathan Eibl
Clark Fjeld
Thomas Yager
Staci McAdams
Kevin Hawkins
Chad Galderisi
Show All
Source
Cite
Save
Citations (0)
Phasing Analysis Of TKI Resistance Mutations In The BCR-ABL1 Kinase Domain and Neighboring Domains Using Next-Generation Sequencing
2013
Blood
Jin Li
Z. Yan
Agus Darwanto
Peng Fang
Weihua Liu
Kristy Drafahl
Julie Toplin
Cindy Spittle
Chad Galderisi
Show All
Source
Cite
Save
Citations (0)
1